What does Morgan Stanley's Counterpoint Global invest in?
Morgan Stanley's Counterpoint Global invests most often at Series B and Series E (100% of the rounds on record).
Last cheque observed Sep 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietGrowth equity
Follow Morgan Stanley's Counterpoint Global and see its new cheques in your feed.Start following
2 rounds on record
Mostly Series B and Series E: 100% of its rounds
Every round we can evidence, newest first2 appearances
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as Morgan Stanley's Counterpoint Global. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Morgan Stanley's Counterpoint Global put money into.
Morgan Stanley's Counterpoint Global invests most often at Series B and Series E (100% of the rounds on record).
2 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2025.
Its most recent investments on record: PsiQuantum (Series E, Sept 2025) and Commonwealth Fusion Systems (Series B, Aug 2025).
The median round it joins is $932M.
No investments in the last 12 months; the latest was in Sept 2025.
Most often Nvidia's NVentures (2 rounds together) and Temasek Holdings (2 rounds together).
Morgan Stanley's Counterpoint Global is a growth equity firm.
From 4 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it